Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calcium Supplementation Linked To Lower Fracture Rates In Meta-Analysis

This article was originally published in The Tan Sheet

Executive Summary

Calcium supplementation, with or without vitamin D, was associated with higher levels of bone mineral density and lower rates of fracture in patients aged 50 or older, according to findings from a large meta-analysis

You may also be interested in...



Dietary Calcium Intake Better Than Supplemental For BMD – NIH Study

Consumption of calcium from dietary sources may lead to greater bone mineral density than calcium intake from supplements, according to a study funded by the National Institutes of Health and recently published in The American Journal of Clinical Nutrition

Novel Omega-3 Formulation Found To Shrink Colorectal Polyps

A high-dose, purified form of an omega-3 fatty acid shrunk colorectal polyps about as effectively as the non-steroidal anti-inflammatory drug commonly used to treat them, but without the associated cardiovascular risks, according to findings from a trial published in the journal Gut

Novel Omega-3 Formulation Found To Shrink Colorectal Polyps

A high-dose, purified form of an omega-3 fatty acid shrunk colorectal polyps about as effectively as the non-steroidal anti-inflammatory drug commonly used to treat them, but without the associated cardiovascular risks, according to findings from a trial published in the journal Gut

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel